Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia

M. Ikeda, N. Ozaki, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, T. Kishi, Y. Sekine, M. Iyo, M. Harano, T. Komiyama, M. Yamada, I. Sora, H. Ujike, T. Inada, N. Iwata

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Recent investigations suggest that the AKT/glycogen synthase kinase 3 (GSK3) signaling cascade may be associated with the pathophysiology of schizophrenia and methamphetamine (METH) use disorder. One important molecule related to this cascade is β-arrestin 2 (ARRB2). We therefore conducted a genetic case-control association analysis of the gene for ARRB2 with schizophrenia and METH use disorder in a Japanese population (547 people with schizophrenia, 177 with METH use disorder and 546 controls). A possible association of 'tag single nucleotide polymorphisms (SNPs)' was found in METH use disorder (rs1045280: Pgenotype = 0.0118, Pallele = 0.00351; rs2036657: Pallele = 0.0431; rs4790694: Pgenotype = 0.0167, Pallele = 0.0202), but no association was found with schizophrenia. We also evaluated the gene-gene interactions among ARRB2, AKT1, and GSK3B, which we previously reported for each of these diseases. However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder.

Original languageEnglish
Pages (from-to)107-112
Number of pages6
JournalGenes, Brain and Behavior
Volume6
Issue number1
DOIs
Publication statusPublished - 01-02-2007

All Science Journal Classification (ASJC) codes

  • Genetics
  • Neurology
  • Behavioral Neuroscience

Fingerprint Dive into the research topics of 'Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Ikeda, M., Ozaki, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kishi, T., Sekine, Y., Iyo, M., Harano, M., Komiyama, T., Yamada, M., Sora, I., Ujike, H., Inada, T., & Iwata, N. (2007). Possible association of β-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes, Brain and Behavior, 6(1), 107-112. https://doi.org/10.1111/j.1601-183X.2006.00237.x